Cancer Clinical Trials
The Koontz Center for Advanced Breast Cancer is the region’s first and only program dedicated to the treatment of metastatic breast cancer.
I Want to Know My Options
Currently Enrolling
The Koontz Center is currently enrolling patients in the following trials specifically targeting advanced breast cancer.
- Development and Implementation of The Breast Cancer Collaborative Registry (BCCR)
- SGNTUC-025-A single arm, open label phase 2 study of tucatinib in combination with trastuzumab deruxtecan in subjects with previously treated unresectable locally-advanced or metastatic Her2+ breast cancer
- A compassionate use study of leronlimab (PRO140) plus treatment of physician's choice in patients with CCR5+ metastatic triple-negative breast cancer
Learn More
Get to know the Koontz Center for Advanced Breast Cancer: